Please assess the completion status of the following clinical trial:

Trial Title: Clobazam in Patients With Lennox-Gastaut Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patient must have been \<11 years of age at the onset of LGS.~* Patient must have LGS.~* Patient must be on at least 1 AED.~* Parent or caregiver must be able to keep an accurate seizure diary.~Exclusion Criteria:~* Etiology of patient's seizures is a progressive neurologic disease. Patients with tuberous sclerosis will not be excluded from study participation, unless there is a progressive tumor.~* Patient has had an episode of status epilepticus within 12 weeks of baseline.~* Patient has had an anoxic episode requiring resuscitation within 6 months of screening.~* Patient has a clinically significant history of an allergic reaction or significant sensitivity to benzodiazepines.~* Patient is taking more than 3 concurrent AEDs.~* Patient has been on the ketogenic diet for less than 30 days prior to screening or suffers from frequent stooling.~* If the patient has a Vagal Nerve Stimulator (VNS), the settings have not been stable for at least 30 days prior to screening.~* Patient has taken corticotropins in the 6 months prior to screening.~* Patient is currently taking long-term systemic steroids (excluding inhaled mediation for asthma treatment) or any other daily medication known to exacerbate epilepsy. An exception will be made of prophylactic medication, for example, for idiopathic nephrotic syndrome or asthma.~* If the patient is taking felbamate, has been taking it for less than 1 year prior to screening.~Other protocol-defined inclusion and exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Clobazam Low Dose (Type: EXPERIMENTAL): None
- Clobazam Medium Dose (Type: EXPERIMENTAL): None
- Clobazam High Dose (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).